Linus Pauling was one of the vital sensible scientists of the twentieth century. He gained two Nobel prizes and remodeled our understanding of chemical bonds and the construction of proteins. Late in his profession, although, he turned well-known for one thing very completely different: a passionate perception that very excessive doses of vitamin C may assist folks with most cancers. Many medical doctors scoffed. When Pauling himself later died of most cancers aged 93, he was held up as a traditional case of the “halo impact”: being a genius in a single area doesn’t assure knowledge in one other.
Half a century on, the story appears to be like extra difficult. Pauling was flawed in essential methods, however he was not solely flawed. Fashionable analysis is giving vitamin C a re-evaluation in most cancers, and it seems that underneath sure situations it may well behave much less like a mild vitamin and extra like a drug.
Pauling’s vitamin C story started within the Seventies, when he teamed up with the Scottish physician Ewan Cameron and gave sufferers with superior, incurable most cancers very massive quantities of vitamin C – first as a drip right into a vein, then as tablets. In contrast with comparable sufferers who didn’t get vitamin C, they reported that the vitamin‑handled group lived longer and felt higher. For some, they prompt, survival could possibly be a number of occasions longer.
Two massive trials, run by the Mayo Clinic, a number one non-profit medical heart within the US, then put this to the check. The outcomes have been clear: there was no profit.
Sufferers who took vitamin C tablets lived not than those that didn’t. For many oncologists, that was the top of the matter. Vitamin C was filed away with different “different” treatments, and Pauling’s late-career campaign was broadly seen as a tragic mistake.
What neither trial’s critics nor defenders seen on the time: Pauling and Cameron had began with vitamin C right into a vein; the Mayo Clinic trials used tablets solely. That issues as a result of the intestine can solely take up a lot vitamin C. When you attain a modest day by day dose, the physique merely stops taking in rather more. Swallow as many tablets as you want, and the extent of vitamin C in your blood ranges off.
Against this, a drip right into a vein can increase blood ranges to tens and even lots of of occasions greater than tablets ever may. At these excessive ranges, vitamin C begins to behave in another way inside the physique.
At on a regular basis ranges, vitamin C acts as an antioxidant: it mops up dangerous molecules and protects our cells. At very excessive ranges, particularly round tumors, it may well flip roles.
In laboratory research, high-dose vitamin C helps generate hydrogen peroxide, a reactive substance that may harm cells. Most cancers cells appear particularly weak as a result of they’re already underneath stress. They develop quickly, typically in areas with poor blood provide, and produce plenty of reactive molecules of their very own. Their inner “cleanup” methods are stretched skinny.
Add a sudden pulse of hydrogen peroxide and plenty of most cancers cells tip over the edge: their DNA and power equipment are broken they usually die. Regular cells, that are underneath much less pressure and have higher defenses, are extra more likely to survive. On this method, very excessive doses of vitamin C behave much less like a day by day complement and extra like a weak, selective chemotherapy drug. Crucially, the doses wanted for this impact can’t be reached with tablets.
What the newest proof exhibits
In folks, the proof remains to be early and blended. Small trials have given high-dose vitamin C by a vein to sufferers with hard-to-treat cancers equivalent to ovarian, pancreatic or mind tumors. Up to now, many sufferers can obtain massive doses a number of occasions a week with out critical side-effects. Issues can happen, particularly in folks with poor kidney operate or uncommon inherited situations, which is why this isn’t a innocent wellness drip to be offered on the excessive avenue.
A number of research counsel that including vitamin C infusions to chemotherapy could assist some sufferers dwell somewhat longer or assist with side-effects, however different research present no clear profit. The trials are small and diverse, so we can’t draw agency conclusions.
One constant sign is high quality of life: sufferers given vitamin C alongside chemotherapy typically report much less fatigue, much less ache and fewer side-effects, equivalent to nausea. For somebody with superior most cancers, that issues, even when it’s not the sweeping remedy Pauling as soon as promised.
Lab work additionally hints at subtler roles. Vitamin C is concerned in enzymes that affect how our DNA is “marked” and skim, and in how cells divide and reply to low oxygen – essential in most cancers conduct.
In some experiments, excessive vitamin C ranges make most cancers cells develop much less aggressively and make them extra delicate to remedy. There are even early solutions that vitamin C could assist the immune system acknowledge and assault tumors, although this stays speculative.
Partly proper
So, was Pauling proper in spite of everything? The fairest reply is that he was partly proper, for causes he didn’t totally perceive, and he exaggerated the promise. He was flawed to advertise vitamin C tablets as a highly effective remedy for most cancers. Giant, cautious trials haven’t discovered that swallowing high-dose vitamin C helps folks with established most cancers dwell longer. He was additionally flawed to current vitamin C as a near-universal treatment for a lot of diseases.
However he was not solely flawed to suspect that vitamin C may need a particular function in most cancers remedy. He sensed, lengthy earlier than we may show it, that very excessive doses given right into a vein would behave fairly in another way from odd dietary supplements.
Fashionable analysis has confirmed that intravenous vitamin C reaches a lot greater ranges within the blood and has distinct organic results. What we don’t but have are massive, definitive randomized trials displaying that high-dose intravenous vitamin C clearly prolongs life for many most cancers sufferers. Till we do, it ought to be seen as experimental – promising sufficient to review, however not confirmed sufficient to interchange customary therapies. Any use belongs in scientific trials or in fastidiously supervised medical settings, not in clinics promoting costly “immune boosts.”
The “nutritional vitamins in most cancers” story continues to evolve. If the story of vitamin C and most cancers teaches us something, it’s that science hardly ever strikes in straight strains. A daring concept, some flawed early research, a fierce backlash – after which, years later, a quieter, extra cautious return to the query.
Pauling could by no means be totally vindicated, however neither was he merely deluded. In his enthusiasm, he could have glimpsed a sliver of fact lengthy earlier than the remainder of us knew the way to search for it.
